• Home
  • About us
  • Log-In
  • Join Us
  • Sitemap
  • Recruit
제품/실험 Q&A
자주묻는질문
자유게시판
실험기법
자료신청
논문자료
클레임 접수
기기 A/S 접수
클레임 진행조회
 제품안내  신경약학   Pharmacology

Metabotropic Glutamate Receptor

Metabotropic Glutamate Receptor agonist & antagonist를 소개합니다.

TOCRIS
제품 문의하기
인쇄하기

    Metabotropic Glutamate Receptor Data
    Receptor Subtype Group I Group II Group III PLD Coupled mGlu Receptor
    Subtypes mGlu1
    mGlu5
    mGlu2
    mGlu3
    mGlu4
    mGlu6
    mGlu7
    mGlu8
    Undetermined
    Transduction Mechanism ↑ PLC ↓ AC ↓ AC ↑ PLD
    Example Agonists L-Quisqualic acid (0188)
    (S)-3,5-DHPG (0805)
    tADA (0860)
    CHPG (1049)
    DCG-IV (0975)
    L-CCG-I (0333)
    (2R,4S)-APDC (1208)
    LY 379268 (2453)
    LY 354740 (3246)
    L-AP4 (0103)
    (S-3,4-DCPG (1302)
    ACPT I (1111)
    (R,S-PPG (1220)
    VU 0155041 (3248)
    L-CSA (0216)
    Example Antagonists CPCCOEt (1028)
    AIDA (0904)
    Fenobam (2386)
    MPEP (1212)
    LY 367385 (1237)
    YM 298198 (2448)
    (RS)-APICA (1073)
    EGLU (0971)
    LY 341495 (1209)
    CPPG (0972)
    MAP4 (0711)
    MSOP (0803)
    UBP 1112 (1369)
    MMPIP (2963)
    (RS)-3,5-DHPG (0342)
    Properties of Selected Metabotropic Glutamate Receptor Antagonists

    Group I

    Antagonist mGlu1a mGlu5a mGlu2 mGlu3 mGlu4 mGlu6 mGlu7 mGlu8
    (S)-MCPG (0337) 124-543 (Kb) 154-460 (Kb)
    > 2000 (Kb)
    15 (Ki) 317 (Ki) > 1000 (IC50) > 100 (IC50) > 1000 (IC50) 320 (IC50)
    (S)-4CPG (0323) 15-182 (Kb) > 1000 (Kb)
    145 (Kb)
    > 300 (Kb)
    366 (Ki)
    Weak agonist
    ND > 1000 (IC50) Weak agonist ND Agonist
    (S)-4C3HPG (0320) 11.5-393 (Kb) 157 (Kb)
    Agonist ND > 1000 (IC50) ND ND Agonist
    AIDA (0904) 3.4 (pKb) > 1000 (IC50) Weak agonist ND > 1000 (IC50) ND ND ND
    CPCCOEt (1028) 4.76 (pKb) > 100 (IC50) > 100 (IC50) ND > 100 (IC50) ND > 100 (IC50) > 100 (IC50)
    MPEP (1212) > 100 (IC50) 0.032 (IC50) > 100 (IC50) ND > 100 (IC50) > 100 (IC50) > 100 (IC50) ND
    SIB 1757 (1215) > 1000 (IC50) 0.4 (IC50 > 30 (IC50) ND > 30 (IC50) > 30 (IC50) > 30 (IC50) > 30 (IC50)
    SIB 1893 (1214) > 30 (IC50) 0.3 (IC50) > 30 (IC50) ND > 30 (IC50) > 30 (IC50) > 30 (IC50) > 30 (IC50)
    LY 367385 (1237) 8.8 (IC50) > 100 (IC50) ND ND ND ND ND ND
    3-MATIDA (2196) 6.3 (IC50) > 300 (IC50) > 300 (IC50) ND > 300 (IC50) ND ND ND

    Group II and III

    Antagonist mGlu1a mGlu5a mGlu2 mGlu3 mGlu4 mGlu6 mGlu7 mGlu8
    MPPG (0853) 1100 (IC50) No effect 12 (Ki) ND 22 (KD) 138 (Kb) ND 20 (IC50)
    MAP4 (0711) No effect ND 15 (Ki)
    Weak agonist
    ND 36 (KD)
    190 (Ki)
    Weak moderate agonist ND 25 (IC50)
    DCG IV (0975) 389 (IC50) 630 (IC50)
    Agonist Agonist 22.5 (IC50) 39.6 (IC50) 40.1 (IC50) 32 (IC50)
    ACPT-II (1112) 115 (Kb) ND 88 (Kb) ND 77 (Kb) ND ND 123 (IC50)
    LY 341495 (1209) 6.8 (IC50) 8.2 (IC50) 0.002 (Ki) 0.001 (Ki) 22 (IC50) ND 0.99 (IC50) 0.173 (IC50)
    References
  • Doherty et al (1999) Br.J.Pharmacol. 126 205. Lin et al (1997) Neuropharmacology 36 917. Brabet et al (1995) Neuropharmacology 34 895. Cartmell et al (1998) Br.J.Pharmacol. 123 497. Laurie et al (1995) Naunyn-Schmied.Arch.Pharmacol. 351 565. Hayashi et al (1994) J.Neurosci. 14 3370. Laurie et al (1997) Neuropharmacology 36 145. Saugstad et al (1994) Mol.Pharmacol. 45 367. Saugstad et al (1997) Mol.Pharmacol. 51 119. Thomsen et al (1994) Eur.J.Pharmacol.Mol.Pharmacol.Sect. 267 77. De Colle et al (2000) Eur.J.Pharmacol. 394 17. Kingston et al (1995) Neuropharmacology 34 887. Brauner-Osborne et al (1998) Eur.J.Pharmacol. 350 311. Hermans et al (1999) Br.J.Pharmacol. 126 873. Moroni et al (1997) J.Pharmacol.Exp.Ther. 281 721. Hermans et al (1998) Neuropharmacology 37 1645. Litschig et al (1999) Mol.Pharmacol. 55 453. Gasparini et al (1999) Neuropharmacology 38 1493. Varney et al (1999) J.Pharmacol.Exp.Ther. 290 170. Thomsen et al (1996) Mol.Pharmacol. 50 6. Kowal et al (1998) Soc.Neurosci.Abstr. 24 576. Abe et al (1992) J.Biol.Chem. 267 13361. Sekiyama et al (1996) Br.J.Pharmacol. 117 1493. Brabet et al (1998) Neuropharmacology 37 1043. Acher et al (1997) J.Med.Chem. 40 3119. Clark et al (1997) Bioorg.Med.Chem. 7 2777. Johnson et al (1999) Neuropharmacology 38 1519. Moroni et al (2002) Neuropharmacology 42 741.